FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Ferriprox (deferiprone) submitted by Chiesi USA, Inc., updating/expanding the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Transfusion-dependent Thalassemia

Drugs mentioned

• FERRIPROX (deferiprone)

Snippet

SUPPL AP for FERRIPROX (DEFERIPRONE)